Bruker (BRKRP) Return on Capital Employed (2011 - 2026)
Bruker (BRKRP) reported Return on Capital Employed of 0.96% for Q1 2026, down 390.0% on a YoY basis from 0.33% in Q1 2025, and down 28.45% quarter-over-quarter from 1.35% in Q4 2025.
Bruker (BRKRP) Return on Capital Employed (2011 - 2026) Analysis & Trends
Bruker has reported Return on Capital Employed for 16 years, with the latest figure at 0.96% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 390.0% year-over-year to 0.96%; the trailing twelve-month figure through Mar 2026 stood at 0.96% (down 390.0% YoY), and the FY2025 full-year result was 1.44%, down 532.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 0.96%, down from 1.35% in the prior quarter.
- The five-year high for Return on Capital Employed was 17.39% in Q1 2023, with the low at 0.96% in Q1 2026.
- Historically, Return on Capital Employed has averaged 10.35% across 5 years, with a median of 11.86% in 2024.
- Annual changes were most pronounced in 2023 — Return on Capital Employed soared 192 bps — and 2024, when it tumbled 1072 bps.
- Bruker's Return on Capital Employed stood at 16.9% in 2022, then decreased by 9 bps to 15.42% in 2023, then plunged by 65 bps to 5.41% in 2024, then sank by 75 bps to 1.35% in 2025, then fell by 28 bps to 0.96% in 2026.
- The last three Return on Capital Employed figures came in at 0.96% (Q1 2026), 1.35% (Q4 2025), and 1.25% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Bruker | - | - | 379.80 Mn | 0.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.96% |
| Dec 31, 2025 | 1.35% |
| Sep 30, 2025 | 1.25% |
| Jun 30, 2025 | 3.84% |
| Mar 31, 2025 | 4.86% |
| Dec 31, 2024 | 5.41% |
| Sep 30, 2024 | 6.07% |
| Jun 30, 2024 | 8.74% |
| Mar 31, 2024 | 11.86% |
| Dec 31, 2023 | 15.42% |
| Sep 30, 2023 | 16.79% |
| Jun 30, 2023 | 17.08% |
| Mar 31, 2023 | 17.39% |
| Dec 31, 2022 | 16.90% |
| Sep 30, 2022 | 17.11% |
| Jun 30, 2022 | 15.44% |
| Mar 31, 2022 | 15.47% |
| Dec 31, 2021 | 16.87% |
| Sep 30, 2021 | 18.33% |
| Jun 30, 2021 | 17.50% |